Latest filing published 21 Feb 2023 for Maxlinear, INC, €8,046.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +40.8%Entry US$4.48 · Close at T+365 US$6.31
- +14.5%Entry US$5.30 · Close at T+365 US$6.07
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Curtis Ling: trading record in brief
All filings by Curtis Ling on record concern Maxlinear, Inc, in the capacity of senior executive. The record holds 361 filings, for trades running from 29 March 2010 to 20 February 2023.
Market trades split into 4 purchases (€48k) and 174 sales (€6.2M). Taken together, the sales exceed the purchases by €6.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 92 share grants and 57 option exercises.
A typical purchase (the median) is worth €10k. After 4 purchases with a full 90-day history, the hit rate stands at 25% and the median 90-day move at -6.6%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 21 February 2023: a share grant of €8,046, in Maxlinear, Inc. The clock since the last published purchase (29 May 2012) now reads 5,276 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Curtis Ling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 234 shares@ US$36.740.1% of flowCommon StockSEC:0001288469-23-000067:1
- 234 shares0Common StockSEC:0001288469-23-000067:0
- 2,664 shares@ US$38.870.7% of flowCommon StockSEC:0001288469-23-000048:1
- 25,064 shares0Common StockSEC:0001288469-23-000048:2
- 16,707 shares0Common StockSEC:0001288469-23-000048:3
- 407 shares0Common StockSEC:0001288469-23-000048:4
- 272 shares0Common StockSEC:0001288469-23-000048:5
- 4,690 shares0Common StockSEC:0001288469-23-000048:0
- 9,000 shares0Common StockSEC:0001288469-22-000192:0
- 7,780 shares@ US$38.452.1% of flowCommon StockSEC:0001288469-22-000113:1
- 7,780 shares0Common StockSEC:0001288469-22-000113:0
- 1,252 shares@ US$60.830.5% of flowCommon StockSEC:0001288469-22-000059:1
- 1,252 shares0Common StockSEC:0001288469-22-000059:0
- 1,823 shares@ US$60.380.7% of flowCommon StockSEC:0001288469-22-000043:1
- 4,094 shares@ US$60.381.6% of flowCommon StockSEC:0001288469-22-000043:3
- 2,729 shares@ US$60.381.1% of flowCommon StockSEC:0001288469-22-000043:5
- 6,310 shares@ US$60.382.4% of flowCommon StockSEC:0001288469-22-000043:7
- 4,207 shares@ US$60.381.6% of flowCommon StockSEC:0001288469-22-000043:9
- 7,596 shares0Common StockSEC:0001288469-22-000043:2
- 5,064 shares0Common StockSEC:0001288469-22-000043:4
- 11,696 shares0Common StockSEC:0001288469-22-000043:6
- 7,798 shares0Common StockSEC:0001288469-22-000043:8
- 3,152 shares0Common StockSEC:0001288469-22-000043:0
- 16,830 shares0Common StockSEC:0001288469-21-000282:0
- 1,251 shares@ US$70.680.6% of flowCommon StockSEC:0001288469-21-000261:1
25 of 355 declarations